139 related articles for article (PubMed ID: 569207)
1. Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol.
Yoshimura H; Watanabe K; Oguri K; Fujiwara M; Ueki S
J Med Chem; 1978 Oct; 21(10):1079-81. PubMed ID: 569207
[TBL] [Abstract][Full Text] [Related]
2. 9 alpha, 10 alpha-epoxyhexahydrocannabinol formation from delta 9-tetrahydrocannabinol by liver microsomes of phenobarbital-treated mice and its pharmacological activities in mice.
Narimatsu S; Yamamoto I; Watanabe K; Yoshimura H
J Pharmacobiodyn; 1983 Aug; 6(8):558-64. PubMed ID: 6315913
[TBL] [Abstract][Full Text] [Related]
3. Identification and determination of 11-oxo-delta8-tetrahydrocannabinol as an intermediate metabolite of delta8-tetrahydrocannabinol in the mouse brain and liver.
Watanabe K; Yamamoto I; Oguri K; Yoshimura H
J Pharmacobiodyn; 1980 Dec; 3(12):686-91. PubMed ID: 6268770
[TBL] [Abstract][Full Text] [Related]
4. Marihuana-like activity of new synthetic tetrahydrocannabinols.
Martin BR; Dewey WL; Harris LS; Beckner J
Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
[TBL] [Abstract][Full Text] [Related]
5. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Watanabe K; Yamamoto I; Yoshimura H
Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
[TBL] [Abstract][Full Text] [Related]
6. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol.
Handrick GR; Duffley RP; Lambert G; Murphy JG; Dalzell HC; Howes JF; Razdan RK; Martin BR; Harris LS; Dewey WL
J Med Chem; 1982 Dec; 25(12):1447-50. PubMed ID: 6296389
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
Nagai K; Watanabe K; Narimatsu S; Gohda H; Matsunaga T; Yamamoto I; Yoshimura H
Biol Pharm Bull; 1993 Oct; 16(10):1008-13. PubMed ID: 8287029
[TBL] [Abstract][Full Text] [Related]
8. Comparison in mice of pharmacological effects of delta 8-tetrahydrocannabinol and its metabolites oxidized at 11-position.
Watanabe K; Yamamoto I; Oguri K; Yoshimura H
Eur J Pharmacol; 1980 Apr; 63(1):1-6. PubMed ID: 6247159
[No Abstract] [Full Text] [Related]
9. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols.
Huffman JW; Liddle J; Duncan SG; Yu S; Martin BR; Wiley JL
Bioorg Med Chem; 1998 Dec; 6(12):2383-96. PubMed ID: 9925296
[TBL] [Abstract][Full Text] [Related]
10. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
[TBL] [Abstract][Full Text] [Related]
11. Characterization of microsomal alcohol oxygenase catalyzing the oxidation of 7-hydroxy-delta 8-tetrahydrocannabinol to 7-oxo-delta 8-tetrahydrocannabinol in rat liver.
Matsunaga T; Shibayama K; Higuchi S; Tanaka H; Watanabe K; Yamamoto I
Biol Pharm Bull; 2000 Jan; 23(1):43-6. PubMed ID: 10706409
[TBL] [Abstract][Full Text] [Related]
12. Monkey hepatic microsomal alcohol oxygenase: purification and characterization of a cytochrome P450 enzyme catalyzing the stereoselective oxidation of 7alpha- and 7beta-hydroxy-delta8-tetrahydrocannabinol to 7-oxo-delta8-tetrahydrocannabinol.
Matsunaga T; Iwawaki Y; Komura A; Watanabe K; Kageyama T; Yamamoto I
Biol Pharm Bull; 2002 Jan; 25(1):42-7. PubMed ID: 11824554
[TBL] [Abstract][Full Text] [Related]
13. Enhancement by alpha-fluoromethylhistidine of the thiopental sleep-prolonging action of delta 9-tetrahydrocannabinol.
Oishi R; Itoh Y; Nishibori M; Saeki K; Ueki S
Psychopharmacology (Berl); 1988; 95(1):77-81. PubMed ID: 2838862
[TBL] [Abstract][Full Text] [Related]
14. Stimulatory effects of testosterone and progesterone on the NADH- and NADPH-dependent oxidation of 7beta-hydroxy-delta8-tetrahydrocannabinol to 7-oxo-delta8-tetrahydrocannabinol in monkey liver microsomes.
Funahashi T; Tanaka Y; Yamaori S; Kimura T; Matsunaga T; Ohmori S; Kageyama T; Yamamoto I; Watanabe K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):358-67. PubMed ID: 16272754
[TBL] [Abstract][Full Text] [Related]
15. Hashish. Unsaturated side-chain analogues of delta8-tetrahydrocannabinol with potent biological activity.
Razdan RK; Dalzell HC; Herlihy P; Howes JF
J Med Chem; 1976 Nov; 19(11):1328-30. PubMed ID: 1003411
[TBL] [Abstract][Full Text] [Related]
16. 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
Huffman JW; Liddle J; Yu S; Aung MM; Abood ME; Wiley JL; Martin BR
Bioorg Med Chem; 1999 Dec; 7(12):2905-14. PubMed ID: 10658595
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of halogenated delta 8-THC analogs.
Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A
Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activities in the mouse of delta 9-tetrahydrocannabinol metabolites oxidized at the 8-position.
Narimatsu S; Matsubara K; Shimonishi T; Watanabe K; Yamamoto I; Yoshimura H
Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):392-5. PubMed ID: 2988803
[No Abstract] [Full Text] [Related]
19. Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives.
Usami N; Kobana K; Yoshida H; Kimura T; Watanabe K; Yoshimura H; Yamamoto I
Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1462-7. PubMed ID: 9775440
[TBL] [Abstract][Full Text] [Related]
20. Competitive inhibition of delta8-tetrahydrocannabinol and its active metabolites for cannabinoid receptor binding.
Yamamoto I; Kimura T; Kamei A; Yoshida H; Watanabe K; Ho IK; Yoshimura H
Biol Pharm Bull; 1998 Apr; 21(4):408-10. PubMed ID: 9586583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
